A Study of the Value of p53, HER2, and Bcl-2 in the Prediction of Response to Doxorubicin and Paclitaxel as Single Agents in Metastatic Breast Cancer: A Companion Study to EORTC 10923
2000 ◽
Vol 1
(3)
◽
pp. 233-240
◽
A. Hamilton
◽
D. Larsimont
◽
R. Paridaens
◽
M. Drijkoningen
◽
M. van de Vijver
◽
...